1,8-naphthalimide-based DNA intercalators and anticancer agents: a systematic review.
Aeyaz Ahmad Bhat, Amel Gacem, Maytham T Qasim et al.
✦ AI-curated · Sources linked
In 30 seconds
This systematic review surveys recent design and biological evaluation of 1,8-naphthalimide-based DNA intercalators investigated as anticancer agents. It groups compounds into mono-intercalators, fused-ring-extended analogs, photoactive agents, bifunctional conjugates, and organometallic hybrids, and discusses their structure–activity relationships, cytotoxic profiles, and proposed mechanisms. The review highlights DNA intercalation, Topoisomerase I/II inhibition, and photoinduced DNA cleavage as mechanisms associated with anticancer activity. It reports no pooled quantitative efficacy estimate or clinical outcome; its focus is on preclinical compound classes and their potential to inform future therapeutic design.
Key findings
- The review organizes compounds into five classes: mono-intercalators, fused-ring-extended analogs, photoactive agents, bifunctional conjugates, and organometallic hybrids.
- Mechanisms discussed include DNA intercalation, Topoisomerase I/II inhibition, and photoinduced DNA cleavage.
- The review considers structure–activity relationships and cytotoxic profiles across the compound classes.
Why it matters
The review brings together structural and mechanistic information across a diverse group of experimental anticancer compounds. This may help researchers identify design principles and compare candidate classes, while clarifying that reported cytotoxicity and mechanisms do not by themselves establish clinical benefit.
What to keep in mind
The abstract describes a review of compound design and biological evaluation but provides no quantitative synthesis or clinical outcome data.